Clinical Trial Update: Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of aliskiren/amlodipine, with or without hydrochlorothiazide, in patients with Stage II hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)
• Amlodipine (amlodipine)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Novartis | Conditions: Stage II Hypertension | Phase 4 | Status: COMPLETED